Frontlight ResearchEarly access
Pancreatic cancer trials in China
326 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleDual-Targeting CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma
- Where
- Shenzhen
- Age
- 18 years to 75 years
- People
- 42
- Run by
- Beijing Biotech
See details and how to joinNCT07480928 - Phase 2Taking peopleA Phase II Study Evaluating JAB-21822 Monotherapy in Adult Patients With Pancreatic Cancer and Other Solid Tumors Harboring the KRAS p.G12C Mutation.
- Where
- Beijing, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Nanchang, Nanjing, Nanning, Qingdao, Shanghai, Shenyang, Tianjin, Wuhan, Xi’an, Zhengzhou
- Age
- 18 years and over
- People
- 88
- Run by
- Allist Pharmaceuticals, Inc.
See details and how to joinNCT06008288 - Phase 2Not yet taking people in ChinaSurufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 30
- Run by
- Sun Yat-sen University
See details and how to joinNCT07469956 - No phaseNot yet taking people in ChinaManagement of Pancreatic Cystic Lesions Using Artificial Intelligence Based on EUS and Multimodal Data
- Where
- Wuhan
- Age
- 18 years and over
- People
- 500
- Run by
- Huazhong University of Science and Technology
See details and how to joinNCT07463872 - Phase 1/2Taking peopleClinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C
- Where
- Beijing, Chongqing, Harbin, Nanchang, Nanjing, Shanghai, Shenyang, Tianjin, Wuhan, Xi'an, Zhengzhou
- Age
- 18 years and over
- People
- 72
- Run by
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT06821503 - Phase 2Taking peopleStudy of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 210
- Run by
- Guangzhou JOYO Pharma Co., Ltd
See details and how to joinNCT06895031 - Phase 1Taking peopleStudy of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
- Where
- Beijing, Guangzhou, Hangzhou, Harbin, Hefei, Shanghai, Shenyang, Tianjin, Wuhan, Zhengzhou
- Age
- 18 years and over
- People
- 330 worldwide
- Run by
- I-Mab Biopharma US Limited
See details and how to joinNCT04900818 - Phase 3Taking peopleA Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer
- Where
- Hangzhou, Harbin, Shanghai
- Age
- 18 years to 75 years
- People
- 999
- Run by
- Akeso
See details and how to joinNCT06953999 - No phaseNot yet taking people in ChinaEUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases
- Where
- Wuhan
- Age
- 18 years to 70 years
- People
- 20
- Run by
- Huazhong University of Science and Technology
See details and how to joinNCT07448376 - Phase 2Taking peopleA Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer
- Where
- Shanghai, Tianjin
- Age
- 18 years to 80 years
- People
- 160
- Run by
- Akeso
See details and how to joinNCT07114315 - Phase 2Taking peopleRecombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic Cancer
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 12
- Run by
- Hangzhou Converd Co., Ltd.
See details and how to joinNCT07006077 - No phaseTaking peopleAI-Powered Precision Decision-Making for Pancreatic Diseases
- Where
- Shanghai
- Age
- 18 years to 80 years
- People
- 2,000
- Run by
- Changhai Hospital
See details and how to joinNCT07439757 - Phase 1/2Taking peopleCarbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
- Where
- Beijing, Chengdu, Chongqing, Fuzhou, Haikou, Heilongjiang, Henan, Hunan, Shanghai
- Age
- 18 years to 80 years
- People
- 54
- Run by
- Sichuan Enray Pharmaceutical Sciences Company
See details and how to joinNCT07433283 - Phase 1Taking peopleCAR-NK Cells (CL-NK-003) in Pancreatic Cancer
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 9
- Run by
- Changhai Hospital
See details and how to joinNCT07425483 - Phase 1/2Taking peopleBiomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
- Where
- Beijing
- Age
- 8 years to 85 years
- People
- 85
- Run by
- Essen Biotech
See details and how to joinNCT07410494 - Phase 1/2Taking peopleEBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
- Where
- Beijing
- People
- 83
- Run by
- Essen Biotech
See details and how to joinNCT07410676 - Early phase 1Taking peopleExploratory Clinical Study of Claudin18.2-Targeted Activated DC and CAR-T Therapy in Advanced Pancreatic Cancer.
- Where
- Haikou
- Age
- 18 years to 80 years
- People
- 10
- Run by
- Hainan Cancer Hospital
See details and how to joinNCT07416240 - Phase 2Not yet taking people in ChinaIBI343 Combined With Chemotherapy as Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 40
- Run by
- Zhejiang University
See details and how to joinNCT07415525 - No phaseTaking peopleXH001 Combination With Immunocheckpoint Inhibitor and Chemotherapy for Patients With Resected Pancreatic Cancer
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 28
- Run by
- Wu Wenming
See details and how to joinNCT06353646 - No phaseTaking peopleMRE for Diagnosis of Pancreatic Masses
- Where
- Shenyang
- Age
- 18 years to 80 years
- People
- 200
- Run by
- Yu Shi
See details and how to joinNCT06526442 - Phase 2Taking peopleHRS-4642 in Combination With Nimotuzumab and Chemotherapy for BRPC With KRAS G12D Mutation
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 40
- Run by
- Zhejiang University
See details and how to joinNCT07240766 - No phaseTaking peopleA Prospective Observational Study of First-Line Systemic Therapy Combined With Celiac Plexus Blockade for Advanced Biliopancreatic Cancer With Pain
- Where
- Wuhan
- People
- 103
- Run by
- Tongji Hospital
See details and how to joinNCT07326137 - Phase 3Taking peoplePolymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer
- Where
- Nanjing, Shanghai
- Age
- 18 years to 75 years
- People
- 416
- Run by
- Shanghai Yizhong Pharmaceutical Co., Ltd.
See details and how to joinNCT06752811 - Phase 2Taking peopleNal-IRI/5-FU/LV Chemotherapy Combined With PD-L1 Inhibitor and Multi-target Anti-angiogenic Small Molecule±SBRT as Second-line Therapy in Metastatic Pancreatic Cancer Patients
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 56
- Run by
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT06662006 - Early phase 1Not yet taking people in ChinaClinical Study of CBG131 CAR-T Cell Injection for the Treatment of CLDN18.2-Positive Advanced Gastric and Pancreatic Cancer
- Where
- Wenzhou
- Age
- 18 years to 70 years
- People
- 18
- Run by
- First Affiliated Hospital of Wenzhou Medical University
See details and how to joinNCT07394205